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cost-conscious HIV care that can truly be
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Clinical Trial Research in Correctional Settings
David Alain Wohl, MD
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Prisoners, because of their relatively stable
environments and availability, have historically been attractive, if not preferred,
research subjects. Phase I drug toxicity studies, malaria treatment trials and radiation
exposure experiments have notoriously been
conducted utilizing prison inmates (1-3).
However, with the evolution of research
ethics and subsequent regulations, investigations involving prisoners have undergone
fundamental changes over the past three
decades.
Many advancements in establishing ethical
standards for research conduct have
stemmed from landmark events such as the
Nuremberg "doctors' trials" of 1946; the 1964
statement by the World Medical Association
(WMA), commonly known as the Declaration
of Helsinki, and the convening by the U.S.
Department of Health, Education and
Welfare of the Belmont Commission in 1976
(4-6). While these events have set forth fundamental protection of human research subjects in general, each has also significantly
impacted the use of prisoners in research.
Autonomy in Prison: An Oxymoron?
At the heart of all attempts to codify ethical
research practices is the concept of informed and voluntary consent. The major
codes and commission reports require that
research subjects must agree to participate
in studies free from "coercion," "constraint,"
"duress" or "elements of force." However,
many argue that the prison setting is inherently coercive and severely limits the autonomy of prisoners to make a free choice. An
opposing perspective argues that prisoners
should not be denied the opportunity to
make informed decisions to volunteer for
properly designed research protocols.
The Belmont Commission Report recognizes
the difficult balance between avoiding overt
and subtle coercion of inmates as study sub-

jects and allowing inmates the choice to participate. According to the authors of the
Belmont Report, "On the one hand, it would
seem that the principle of respect for persons requires that prisoners not be deprived
of the opportunity to volunteer for research.
On the other hand, under prison conditions
they may be subtly coerced or unduly influContinued on page 2

HEPP is holding the
following conferences:
Clinical Trials in Corrections
Providence, Rhode Island
October 13-15, 1999
Conference will review the practice and
legal and ethical aspects of clinical trials in
correctional settings. A consensus meeting
on the 15th will seek to identify a consensus on practical guidelines for holding clinical trials. Contact Betsy Stubblefield via
fax (401.863.1243) or e-mail (heppnews@brown.edu), or visit www.hivcorrections.org
HIV/AIDS Behind Bars
Call for Abstracts
HEPP at BRUNAP is sponsoring a preconference colloquium on November 6 at
the NCCHC conference that will discuss
public health and corrections collaborations. Accepting abstracts of 500 words
addressing this topic until September 22.
Please fax (401.863.1243) or e-mail (heppnews@brown.edu) questions to Betsy
Stubblefield. Visit www.hivcorrections.org
for more information.
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Clinical Trial Research in Correctional Settings
Continued from page 1

A personal story:
Can ethical research be performed in correctional settings?
The mention of research in prison for most conjures up images of forced experimentation
on captive human guinea pigs by callous scientists.
However, research practice in prisons has dramatically changed over the past 30 years,
fueled in part by the dark legacies of Nuremberg, Willowbrook and Tuskegee and intense
media scrutiny of suspect human subject research.
The result has been an ongoing examination of how clinical trails are conducted, particularly in so-called 'vulnerable' populations such as prisoners. Can clinical research be
conducted ethically in correctional settings?
As a clinical trialist working with subjects who are incarcerated, I believe the short answer
is a resounding yes. The longer answer, however, adds caution: only if you are able to
continuously and vigilantly act to safeguard that the fundamentals of ethical research are
strictly adhered to. Our HIV clinical research program in prisons emerged from the observation that HIV was concentrated in our state correctional facilities.
Despite this, little was known about issues of integral importance to HIV health care
providers such as inmates attitudes and behaviors regarding their HIV infection, treatment and care.
In addition, it was evident to us, as it has been to others, that response to HIV therapy
appeared to differ from that of the free world, with many inmates experiencing profound
and durable responses to almost minimalistic antiretroviral therapies.
To address these issues, we have embarked on a series of clinical research efforts in our
state prisons. To eliminate overt coercion of potential research subjects, our research
group has gone to great lengths to disabuse patients of the notion that study participation
results in any special rewards. It is made clear that volunteering will not result in special
privileges, diet or access to medical personnel and will not have any impact on length of
sentence or on parole. These points are discussed verbally and are detailed in the
informed consent which is read to potential subjects. (See Heppigram).
We strive to only conduct studies that pose no more than a minimal risk to subjects. The
issue of exposure to risk became a major issue and learning experience when we conducted a treatment trial in which one arm of the study received abacavir. It became evident that some of the incarcerated subjects were unable to immediately contact the study
staff if they suspected they were developing an abacavir hypersensitivity reaction, say,
late one Saturday at a site with no medical staff on duty until Monday. To us, this placed
these subjects at greater risk than those not incarcerated. As a result, we decided to scale
the scope of our study down to facilities with 24 hour-per-day, 7 day-per-week nursing
and developed an appreciation of how research in prison poses unique challenges that
are difficult to anticipate without an understanding of the complexities of a correctional
system.
Research should, in general, aim to benefit the population being studied. Certainly, given
the concentration of HIV in correctional settings, HIV-related research in prisons is appropriate and, I argue, necessary. Recently our group has initiated studies of patterns of antiretroviral adherence and the utility of directly observed therapy in prisons. Other
researchers have elegantly studied the effect of continuity of medical care on recidivism,
while others have reported on inmate attitudes toward condom and bleach availability.
Each of these investigations relates directly to experiences encountered by inmates and
the study results will be applicable to the inmate populations studied.
In the dynamic world of HIV care, time waits for no one. For those doing time we should
offer nothing less than what we offer those who are free, including ethically constructed
clinical research. We are challenged, however, to answer the questions and develop the
innovative therapies that will benefit prisoners and possibly others in way that is moral
and reflects that we have learned a lesson from our past. David Alain Wohl, MD

enced to engage in research activities, for
which they would not otherwise volunteer.
Respect for persons would then dictate that
prisoners be protected." Whether to allow
prisoners to "volunteer" or to "protect" them
presents a dilemma, the report states (6).
The presence of unethical influence over
inmates to enter clinical trials may be overt;
for example, the awarding of special privileges or a sentence reduction. However,
coercion can also be subtle. Increased
access to medical care and opportunities to
interact with others during study-related
activities might constitute undue inducement.
The institutional review boards (IRB) role is
to be vigilant in determining if coercion is
present. The IRB Guidebook, published in
1993 by the National Institutes of Health
(NIH), charges IRBs with determining
whether advantages received by prisoner
subjects are sufficient to impair the inmate's
ability to freely choose to enroll (7).
Which Studies Apply?
Federal policy mandates that only certain
kinds of research are appropriate for prisoner participation. These studies present no
more than a minimal risk to the subject.
Minimal risk is defined as "risk of physical or
psychological harm that is no greater than
that encountered in the routine lives of
healthy persons."(8) Research considered
appropriate for prisoner participation
includes studies of criminal behavior, prison
life, conditions affecting prisoners as a class
and therapies likely to benefit the prisoner
subject. Therefore, phase I and II treatment
trials are not appropriate in correctional settings.
In general, prisoners should not be selected
for research when other, less vulnerable
and burdened populations can address the
scientific question being posed. This issue
of distribution of the burden of research is
addressed in the Belmont Report:
"Social justice requires that distinction be
drawn between classes of subjects that
ought, and ought not, to participate in any
particular kind of research, based on the
ability of members of that class to bear burdens, and on the appropriateness of placing
further burdens on already burdened persons.
Thus, it can be considered a matter of social
justice that there is an order of preference in
the selection of classes of subjects (e.g.,
adults before children), and that some classes of potential subjects (e.g., the institutionalized mentally infirm or prisoners) may be
involved as research subjects, if at all, only
on certain conditions." (6)
Continued on page 4
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Dear Colleagues,
With the end of summer comes the usual flurry of Fall activities. You have already
received notice of HEPP's Clinical Trials in Correctional Settings conference,
scheduled for Oct 13-15 here in Providence (see Save the Dates for more information). We look forward, with excitement, to that meeting, where a who's who of
correctional medical providers will discuss ethical, legal, and operational aspects
of trials with leaders in the fields of medical ethics, HIV research and law. This
issue of HEPP News features a lead article by David Wohl describing the history
of clinical trials, and a "personal" note by David on his own experience in the North
Carolina Department of Corrections.
Since one of the criteria for ethical research is "good clinical practice," it is entirely appropriate that this month's issue also include a description of case management - again in the NC DOC. The program, described by Faye Duffin, fits our idea
of optimal case management, although we believe 48 clients per case manager is
a little high, especially if they have to travel to more than one institution (see reference 6 in her piece). This statement would probably hold true for many states
where HIV case management is operational. Those states that aren't fortunate
enough to have case management may wish to contact Faye Duffin, or her supervisor Medical Director Barbara Pohlman, at the NC DOC, for more information.
This month's issue includes two tools that will be useful to HIV providers in correctional settings. In keeping with our case management features, we have provided you a full page, standardized HIV care flow sheet for the management of the
HIV infected inmate. We've also included a list of criteria for informed consent that
is relevant to the Clinical Trials article. After reading this issue, readers should be
able to list which types of research are appropriate for prisoner participation, identify requirements for prisoner research as described by federal codes and commission reports, and outline the essential components of HIV nurse case management in correctional settings.
Next month, for our First Anniversary Issue, we'll feature an update on HIV treatment by one of our editors, and insights on how a large state system manages to
adapt to rapidly changing clinical guidelines for HIV. We're proud to let you know
that this issue marks our first anniversary, and we'd like to thank you for your continued interest in our publication.
Sincerely,

Anne S. De Groot, MD
Editor, HEPP News
Co-chair, HIV Education/Prison Project

David Thomas, MD
Assistant Chief of Health Services
Florida Department of Corrections
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Update on Optimal Sequencing
of Antiretroviral Therapy, Series
Two: Initiation of Therapy:
Potency vs. Class
CME-accredited telephone conference calls on September 16, and
22, 1999
To register, call 800.433.4584
or e-mail rodell@whcom.com
Sponsored by: Rush-PresbyterianSt. Luke's Medical Center,
Chicago, IL.
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Antiretroviral Update for the
Next Millennium
October 12, 1999
Satellite video conference
Contact: Carol Kiner,
Videoconference coordinator,
Albany Medical Center
e-mail: kinerc@mail.amc.edu
phone: 518.262.4674
fax: 518.262.6335

HEPP News is published twelve times a year by the
Brown University AIDS Program
Box G-H105  Providence RI 02912
tel: 401.863.1725
fax: 401.863.1772
e-mail: brunap@brown.edu
If you have an difficulties with this fax transmission
please call 888.447.1906
Senior Advisory Board
Joe Bick, M.D.
California Dept. of Corrections
Roderic D. Gottula, M.D.
Society for Correctional Physicians
Theodore M. Hammett, Ph.D.
Abt Associates
Ned E. Heltzer, R.Ph., M.S.
Prison Health Services, Inc.
David Thomas, J.D., M.D.
Florida Dept of Corrections
Managers
Dennis Thomas
HIV Education Prison Project
Michelle Gaseau
The Corrections Connection
Layout
Mary Sheehan
The Corrections Connection
Promotion and Distribution
Amanda Butler
Cimon Consulting Group
Editorial Associates
Elizabeth Stubblefield
HIV Education Prison Project
Christine Mastal
The Corrections Connection
Associate Editors
Timothy P. Flanigan, M.D.
Brown University School of Medicine
David P. Paar, M.D.
University of Texas Medical Branch
Anne C. Spaulding, M.D.
Brown University School of Medicine
David A. Wohl, M.D.
University of North Carolina
Betty Rider, M.A., M.S.
North Carolina Division of Prisons
Steve Szebenyi, M.D.
Albany Medical College
Stephen Tabet,
Univ. of Washington
Division of Infectious Disease
Seattle HIVNET

4th National Conference on
Chronic Disease Prevention and
Control: Multi Disciplinary Care
of the HIV-Infected Adult
October 27-29, 1999
Atlanta, GA
Sponsored by: Southeast AIDS
Training and Education Center
Contact: Patricia Yeargin
phone: 404.727.2938
fax: 404.727.4562
e-mail: pyeargin@emory.edu

United States Conference on
AIDS
November 5-8, 1999, Denver, CO
Sponsored by: The National
Minority AIDS Council (NMAC).
Contact: for more information,
call 202.483.6622 x343
or visit www.nmac.org

3

A u g . / S e p t . 1 9 9 9  Vo l u m e 2 , I s s u e 8

v i s i t H E P P N e w s O n l i n e a t w w w. h i v c o r r e c t i o n s . o r g

Clinical Trial Research in Correctional Settings
Continued from page 2

The use of placebos must also be applied
in an ethical manner when research involves vulnerable populations. In the wake
of the Tuskegee syphilis study, where poor
African American men were not informed
that they were part of an infected natural
history cohort, it is imperative that all procedures and treatments be known and
understood by the subject. Placebos can
be used as part of a control group only in
special circumstances and almost never
when administered alone without a concomitant active agent. Use of placebos or
inclusion of an untreated control group
requires approval of the Department of
Health and Human Services if the research
is federally supported (7).
Guidelines for Regulating Prison Research
1976 Belmont Report
http://www.grants.nih.gov/grants/oprr/
humansubjects/guidance/belmont.htm
1989 Revised Version of the Helsinki
Declaration
http://helix.nih.gov:8001/ohsr/helsinki.php3
Office for Protection from Research Risks
(OPRR)
http://grants.nih.gov/grants/oprr/oprr_t.htm
FDA Requirements
http://www.nih.gov/grants/oprr/irb/
irb_guidebook.htm

Confidentiality
Protecting the privacy of prisoners is difficult even when they are not part of a clinical trial. Simply being moved from a cell to

a clinic can make an inmate conspicuous to
others.
In addition, there are breaches of confidentiality when non-medical staff have access
to medical records. Study activity that increases the frequency of clinic visits or
risks confidentiality in other ways must be
minimized. Maintaining confidentiality for
inmates may involve elaborate safeguards
and protections such as storing study related documents separately from the medical
record, integrating study visits with routine
clinic visits and carefully labeling any medication dispensed.
IRBs
The primary responsibility for review and
oversight of clinical research is the IRB. All
research involving prisoners should be
evaluated by an IRB. The board should
meet the requirements specified in the
Code of Federal Regulations [45 CFR
46.304].
Research and Race
A disproportionate number of persons
incarcerated in the United States are members of racial minorities. As such, research
in correctional settings may place a particularly unfair burden on minority prisoners
despite the efforts of the investigators to
fairly select subjects. Historically, the opposite has generally been true; white prisoners have usually been over-represented in
research. This may have been due to
biased selection, allowing white inmates to
benefit from the privileges that were historically associated with participation in
research trials (9).
However, as more members of racial and

ethnic minority groups are incarcerated and
the coercive inducements for study enrollment are eliminated, there is a potential for
minorities to be disproportionately represented in clinical research in prisons.
While individual institutions or investigators
may not be able to resolve a problem that
is pervasive in their social setting, they can
consider distributive justice in selecting
research subjects. This may be accomplished by attempting to have the racial
make-up of the study population reflect that
of the population affected by the disease
being studied. For research investigating
conditions specific to prisoners, the disproportionate inclusion of racial minorities may
be justified as representative of the composition of the prison population.
Summary
Prisoners need to be protected from
research that is exploitative and which can
pose undue risks. Inmates must not be
included in research solely because they
are part of a convenient and readily accessible population. When undue coercion
and influence are minimized to the greatest
degree possible, prisoners may be able to
make an informed decision regarding participation.
It is incumbent upon investigators and
IRBs to be familiar with the regulations
guiding research in correctional settings
and to determine if the proposed research
is suitable for prisoner participation. When
designed and implemented correctly,
research involving prisoners is likely to
benefit inmates as a class, and become an
asset to research in general.

REFERENCES:
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guidelines for the protection of human subjects of research. Washington, D.C.: Government Printing Office, 1983
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SPECIAL REPORT - HIV Case Management In Corrections:
The HIV/AIDS Outreach Program of the North Carolina Division of Prisons
Introduction:
As the director of Nursing and Ancillary Services at the New York State
Department of Correctional Services, it is my pleasure to introduce this piece on
the subject of case management of HIV in the correctional setting. Overseeing
the nursing practice and continuing education needs of over 500 nurses in the
New York State Department of Correctional Services (NYSDOCS), Division of
Health Services, is certainly challenging but rewarding as well. Case management of HIV-infected inmates is inherent in correctional nursing practices in light
of the high HIV profile of prison populations. Provision of care to HIV-infected
inmates takes a focused, coordinated and concerted effort by our health care
professionals- the largest component of which is the professional nursing staff.
This affords the nurses the unique opportunity of fostering and participating in
intra-disciplinary collaboration with their nurse peers.
The following article by Faye Duffin describes North Carolina Department of
Prisons' (NCDOP) HIV Care Model of case management. Outreach Nurses, as
case managers are known in the NCDOP, facilitate early identification, education and prevention of HIV with individualized case management interventions
for the known HIV-infected inmates, emphasizing trust building client-caregiver
relationships. The Outreach Nurses also promote inter-disciplinary collaborations by providing education to all members of correctional staff.
Indeed, the tasks the NCDOP outreach nurses perform seem to be numerous
and critical to the provision of good HIV care, bringing me to my final point: The
most difficult task we engage in as partners in correctional health care is the
budgeting of our time. The standard case-load for an HIV case manager outside
corrections is in the range of 30 to 40 patients, due to the complex nature of HIV
care. Inside corrections, case loads tend to be much higher. Faye Duffin's article accurately reflects the challenges as well as the rewards of HIV case management in the correctional setting.
Christine C. Mulligan, R.N, M.S.
Director of Nursing & Ancillary Services,
N.Y. State Department of Correctional Services

Faye A. Duffin, R.N.,C, B.S.
NCDOP Infection Control Coordinator
The North Carolina General Assembly established the basic structure of
today's HIV care model in the North Carolina Division of Prisons (NCDOP)
in 1994 (1). The model includes three critical components: care directed by
a team of HIV-experienced physicians, a team of outreach nurses focused
on HIV care and education, and comprehensive case management (during
incarceration and discharge planning). Wisely, NCDOP has stayed the
course set by the legislature, providing HIV care that is consistent with current treatment guidelines and community standards (2). This article will
address the role of the case manager, or "outreach" nurse, as we are called
in the NCDOP.
As nurses, we are well aware that almost all of our incarcerated patients
eventually return to the community. Their health status will affect the community as a whole, especially if the inmates are affected by infectious diseases such as HIV, TB and sexually transmitted diseases that they could
transmit to members of their family or community. Often, their conditions
have not been treated because they have had limited access to health care
prior to incarceration. Therefore, prison and jail settings are critical points of
access to address the preventive and primary health care needs of this hard
to reach population, and to plan for interventions that will return them to the
community in good health (3). Our role in the task of preventing and treating
medical conditions in this population will save public and correctional
resources and protect communities to which they return.
Considering the broad scope and importance of integration of services
required to care for inmates with HIV/AIDS, skilled nursing case managers
are an essential part of the health care team (4). Thus at the initiation of the
outreach program in the NCDOP, eleven nurses were hired and trained by
NCDOP to provide patient education, case management and discharge
planning to the HIV-infected inmates in the prison population.
Over the years, the program has evolved to include many of the activities
provided by community outreach programs. Therefore, in keeping with the
nurses' desire to improve patient confidentiality and trust, the nurses chose
to be identified as "Outreach Nurses." The outreach program nurses' role
includes early identification, education and prevention; case management of
the known HIV positive inmate; technical and professional support to staff;
and discharge planning.

Early identification, education and prevention
All new admissions are required to participate in HIV education and prevention sessions at the time of intake. One outreach nurse is assigned to each
intake center. The main purpose of the intake session is to increase awareness of HIV risk factors and behaviors, and to encourage the newly admitted inmates to get tested. We also use this opportunity to provide information on prevention techniques through lectures, interactive group discussions, and videos. We try to cover a broad range of topics in our one intake
session, such as basic HIV pathophysiology, transmission risks, and signs
and symptoms of HIV infection and associated opportunistic infections. We
also offer HIV education and testing programs to incarcerated women, in collaboration with the local health department. Through early intervention with
incarcerated women, we hope to provide information on HIV prevention,
identify women who are infected and in need of treatment, and identify and
treat HIV-infected pregnant women, thereby preventing transmission of HIV
to their children.
Case management for HIV infected inmates
Case management is an integral part of connecting inmates to available services concerning HIV and other health needs (4). By definition, the nurse
case manager or outreach worker assesses, plans, implements, coordinates, monitors, and evaluates the options and services required to meet
each of our patients' health needs, using communication and available
resources to promote quality, cost-effective outcomes (5).
We are each responsible for case management at the prisons in our
assigned region. Once identified, HIV infected inmates are assigned to an
outreach nurse, who then provides that patient with additional education and
counseling sessions. Similar to "outreach nurses" in local communities, we
assist our patients as they navigate through the bureaucratic maze of
HIV/AIDS care in a large and complex system. And, since we are assigned
to more than one institution, our ability to follow patients after transfer to a
new institution provides continuity of care. If, for example, records are not
transferred with the patient, we can provide clinical information on the patient
for the medical staff at the patient's new facility.
We are also responsible for reporting each of our HIV cases to the local
health department and the Centers for Disease Control. For all newly diagnosed positive cases in North Carolina, we are required by law to ask the
patient about the need for partner notification, and to arrange partner notification through the Department of Health and Human Services. Another
important aspect of our job is to make referrals to mental health, chaplain,
substance abuse, or other services as warranted.
Our role permits us to concentrate on educating the patient, allowing the
physician specialist to concentrate on managing the disease. We emphasize
the importance of adherence to treatment regimens and management of
risky behaviors. We explain disease progression, interventions, and treatment, and we emphasize the importance of follow up with the specialists at
the infectious disease clinic. We are responsible for monitoring adherence to
medication, discussing side effects, controlling for medication interactions,
and following up on laboratory test results. We also give the patient information on opportunistic infections.
The key: The client/caregiver relationship
We believe that our system works because the patients learn to trust the outreach workers. Our contact with the patient begins either at the time the HIV
infected patient enters the system, or at the time HIV infection is first identified. Early and frequent contact lays the foundation for a trusting client/caregiver relationship (6)- which is often difficult to achieve with incarcerated
patients. This trusting client/caregiver relationship allows the inmate to discuss problems that he or she might not be comfortable addressing with unit
medical staff. We see each inmate regularly to discuss medication adherence and treatment compliance. We are also available to manage HIV-related problems when a unit nurse contacts us. After discussing the problem
with the nurse, we decide whether we should visit the patient to discuss problems or concerns.
Most of our inmate patients are cooperative with us, and welcome our assistance, even requesting to see us personally when submitting their sick call
forms. A few inmates are less receptive to having us participate in their care.
Our role in those situations is to be sure to monitor the patient, to review the
health care record, and to evaluate the type of symptoms the patient might
be reporting to other health unit workers. We will periodically call on the
Continued on page 7
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A feature of HEPP News providing concise solutions to correctional HIV-related problems.

Components of Informed Consent
This information must be given to the subject in language understandable to the subject. No informed consent, whether oral or written, may
include any exculpatory language through which the subject is made to waive or appear to waive any of the subject's legal rights, or releases or
appears to release the investigator, the sponsor, the institution or its agents from liability for negligence.

Federal regulations require that the following information must be provided to each subject involved in research
[Federal Policy §___.116(a)].
1. A statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental;
2. A description of any reasonably foreseeable risks or discomforts to the subject;
3. A description of any benefits to the subject or to others which may reasonably be expected from the research;
4. A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject;
5. A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained;
6. For research involving more than minimal risk, an explanation as to whether any compensation and an explanation as to whether any medical treatments are available if injury occurs and, if so, what they consist of, or where further information may be obtained;
7. An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact
in the event of a research-related injury to the subject; and
8. A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise
entitled, and the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled.

The regulations further provide that the following additional information be provided to subjects, where appropriate
[Federal Policy §___.116(b)]:
1. A statement that the particular treatment or procedure may involve risks to the subject (or to the embryo or fetus, if the subject is or may
become pregnant) which are currently unforeseeable;
2. Anticipated circumstances under which the subject's participation may be terminated by the investigator without regard to the subject's consent;
3. Any additional costs to the subject that may result from participation in the research;
4. The consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject;
5. A statement that significant new findings developed during the course of the research which may relate to the subject's willingness to continue participation will be provided to the subject; and
6. the approximate number of subjects involved in the study.
The complete regulations are available at: http://www.nih.gov/grants/oprr/irb/irb_chapter3.htm#e2. Special considerations for prisoners are available at: http://www.nih.gov/grants/oprr/irb/irb_chapter6ii.htm#g6

Resources
PROGRAMS:
StadtRelease: A Program for Post Release
Adherence and Community Resources. The
goal of the StadtRelease program is to directly
provide, as well as to coordinate, access to
resources for incarcerated and recently released
HIV positive individuals to maintain health care
and drug therapies during transition from prison
to the free world.
Contact: Kimberly Betty, Stadtlanders
Pharmacy/Corrections Division:
phone: 800.833.2510 x31458
Local Population/Area Epidemiologic Research
on Drug Abuse-NIDA:
Sponsored by: DHHS, NIH, NIDA
Deadline: October 1, November 12, February 1,
2000, and March 12, 2000
This program announcement encourages
research on the local population/area epidemiol-

/

Opportunities

ogy of drug abuse and its correlates and consequences.
Contact: Peter Hartsock
phone: 301.443.6720,
e-mail: ph45z@nih.gov or visit
w w w.nih.gov/grants/guide/pa-files/PA-95059.html
WEB RESOURCES:
HEPP News Website:
www.hivcorrections.org
Adult AIDS Clinical Trials Group (AACTG):
http://aactg.s-3.com/links.htm
National Institute on Allergy and Infectious
Disease (NIAID): http://www.niaid.nih.gov/
American Foundation for AIDS Research:
http://www.amfar.org/

Community Programs for Community Research
on AIDS (CPCRA): http://www.cpcra.org/
HIV Network for Prevention Trials (HIVNET):
http://www.niaid.nih.gov/daids/hivnet.htm
AIDS Clinical Trial
http://www.actis.org/

Information

Service

HIVline: The Clinician's Educational Resource:
www.HIVline.com
NURSING RELATED WEBSITES:
Virginia Henderson International Nursing Library
http://www.stti.iupui.edu/library/
Association of Nurses
http://www.anacnet.org/

in

AIDS

Care
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News Flashes
Update on Prisoners in 1998
Over the past eight years, the prison population has grown 4.8%, according to the recently released Bureau of Justice Statistics
Report, "Prisoners in 1998." The expansion
rate for the women prisoner population was
40 percent higher than the rate for men (6.5%
and 4.7%, respectively). The full report is
available at http://www.ojp.usdoj.gov/bjs/abst
ract/p98.htm.
Access and Cost: Prison Health Care
HEPP editor Frederick L. Altice, MD was
author of a recently published analysis of
state and federal policies affecting correctional care (Pollack, H.A., Khoshnood, K, and
Altice, FL. Health Care Delivery Strategies for
Supervised Offenders. (Lead Article) Journal
of Health Care Finance, 1999; 26(1), pp. 117. [in press]). According to the article, major
problems of correctional care include a growing correctional population, increasingly complex clinical care due to HIV and other diseases, and the unexpected impact of certain
Medicaid policy choices in recent years. The
authors argue for collaboration between correctional health care providers, Medicaid
managed care, and law enforcement in

efforts to address inherent health care delivery problems and develop comprehensive
solutions.
New Correctional Health Care Newsletter
Despite the abundance of information available regarding HIV treatment, there are few
resources that are specifically targeted
toward providers who work in the correctional environment. One year ago, HEPP News
was created to respond to the HIV specialists'
critical need for information on HIV management in the correctional setting. Now we are
pleased to introduce a second resource, HIV
Inside, a new quarterly publication also
accredited through Brown University. While
HEPP News serves the needs of the correctional HIV specialist, HIV Inside was
designed to provide a broader perspective on
HIV management issues to all correctional
professionals, including physicians, physician
assistants, nurses, social workers, dentists,
and administrative personnel. See sign up
box at the end of this issue.
Update from our last issue on Hepatitis C
Two recent journal articles highlighted the
prevalence of HCV in the US (Alter M,

Kruszon-Moran D, et al. NEJM 8/19/99; Vol.
341, No. 8, P. 556; ) and recent treatment
options (Koff R. JAMA 8/11/99; Vol. 282, No.
6, P. 511). Hepatitis C (HCV), hepatitis B
(HBV), and co-infections with HBV and
hepatitis D (HDV) account for approximately
90 percent of chronic viral hepatitis cases in
the United States. Treatment of HBV with
interferon alfa-2b was shown to be both effective and economical, while a new treatment
option, lamivudine (3TC), was well-tolerated
for chronic HBV infection when taken for a
year. Meanwhile, the only effective treatment
for HDV is high-dose interferon alfa, and sustained responses are not common.
Treatment options for HCV were discussed in
the last issue of HEPP News (see archives at
www.hivcorrections.org).
Report from the HIV Cost and Services
Utilization Study (HCSUS)
The June 30, 1999 issue of JAMA features an
update from HCSUS, showing that access to
HIV care has improved over the past three
years, but has remained suboptimal for
Blacks, Latinos, women, the uninsured and
the Medicaid-insured. JAMA. 1999 June
23/30; 281:2305-2315.

HIV Case Management In Corrections:
Continued from page 5
patient to make sure they are aware of our services. This tactic seems to
make the patient aware that we are concerned about their health needs,
encouraging them to engage in care.
Discharge Planning
As inmates prepare for release, outreach nurses make arrangements for follow-up with resources in the community. Upon notification of discharge, we
prepare a package of basic HIV material and a brief resource directory that
directs inmates to resources needed for medical care within the community.
We also initiate the paperwork for drug assistance approval through the
North Carolina AIDS Drug Assistance Program, and we make contact with
the clinics to which the patient will be discharged. It is NCDOP policy to provide patients with up to thirty days of medications upon release. We make
every effort to find housing for the patients when needed. We have the support of the NCDOP and DHHS, as both organizations recognize that connecting the patient with community resources upon release are an important
issue to the incarcerated population.
Upon discharge, we provide the patients with the following:
 A contract to sign that releases his/her medical data, including laboratory test results
· Phone numbers of resources in the community
 Information emphasizing prevention methods to reduce the likelihood
of transmitting HIV infection within their community.
Even with our best efforts, some of our patients are lost to follow up after
returning to the community - often because there are few resources available
in the communities to which they are returning.
At the current time, the NCDOP does not follow up with inmates once they
are released from the system. Since discharge planning and follow-up have
been identified as a major concern for our patient population, a task force is
being developed consisting of public health and correctional personnel. It is
the goal of this committee to develop a collaborative process with community-based organizations which will address our patients' needs at the time of
release, and improve the continuity of care.

Providing a resource for NCDOP staff
One of our newest roles at the NCDOP is to keep health care and correctional staff informed of new developments in the treatment and management
of HIV and AIDS. We are able to stay updated through involvement in state,
regional, and national HIV groups as well as county HIV task forces and
AIDS Services Organizations. Our participation with these groups helps to
provide valuable feedback to the community concerning the issues inmates
face upon discharge.
Our administration recognizes the important role of the nursing staff on the
health care team. As a result, we have become an integral part of the system-wide HIV education and training programs. We provide accurate, current and continuous information to the officers, and seek out opportunities for
dialog. We are now involved in a new initiative to provide basic education on
HIV to all correctional officers within the system. The communication links
between correctional officers and staff enhance our ability to fulfill our many
roles as problem solvers, facilitators, advocates, and educators.
Conclusion
Primary and preventive health care and education for the incarcerated population not only benefits the inmate; it benefits the community where they will
eventually be released. We are in the forefront of innovative nursing because
we bring the "third partner," the correctional officer, to the table. By including the trusting client/caregiver relationship established in our Outreach program, we create a team that brings the best HIV care possible to infected
inmates.
REFERENCES:
(1) General Assembly of North Carolina Extra Session 1994 House Bill 211.
(2) Personal communication. Barbara Pohlman, MD, MPH: Director of the NCDOP
Health Services/Medical Director.
(3) Hammett, Theodore T. Public Health/Corrections Collaborations: Prevention and
Treatment of HIV/AIDS, STDs, and TB. National Institute of Justice/Centers for Disease
Control and Prevention. 1998.
(4) Kirton CA, Ferri RS, Eleftherakis V. Primary care and case management of persons
with HIV/AIDS [Review]. Nurse Clinics of North America. 1999 March; 34(1): 71-94.
(5) Kongstvedt, P.R. "The Managed Health Care Handbook" Third Edition, p. 274.
(6) Thompson AS, et al. Evaluation of an innovative program to address the health and
social service needs of drug-using women with or at risk for HIV infection. Journal of
Community Health. 1998 December; 23(6): 419-40.
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Flow Sheet for the Management of the HIV Infected Patient
Name:____________________________________________________________________ DOB:__________
HIV Dx/Date:______________
HIV risk(s):___________________ Allergies: ________________________
Clinic a l Da t a
Date
Weight
CD4 / (%)
Viral Load
WBC
Hb/HCT
PLT
SGOT/AST
SGPT/ALT
AlkPhos
Bili
Amylase
Lipase
Triglicerides
Cholesterol

A nti re t ro v ira l The ra p y
Date:

He a lth M a i nte na nc e
P P D/d ate:
To xo /d at e:
To x o / d a t e :
Hep S cr een d ate /r esu lt s:

RP R/d ate:
CX R/d at e:
A

P AP /d ate:

/

B

/

C

/

Im m u niz a tions
P n eu mo va x:
Hep A:
Hep B :
In flu en za ( ye arl y):
Oth er :

Pr o p hyl ax is
PCP ___________
MAI ___________
Other ___________
Pr o ble m Lis t
Opportunistic Illnesses

Co n s ult s
Opthamology:________________________________
Opthamology:_______________________
Other:
______________________________________
Other:______________________________

Date

Hos pita liz a tions
Date/dx

Critical Information

National Clinicians PEP Hotline:
888.448.4911
National HIV Telephone Consultation Service:
800.933.3413
HIV/AIDS Treatment Information Service website: www.hivatis.com
HEPP News website: www.hivcorrections.org

Other

Date

Date/dx

Flow Sheet Developed By:
HEPP News Address: Box GB 426 Brown University
Providence, RI 02912
e-mail: heppnews@brown.edu
fax: 401.863.1243
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Spotlight on the North Carolina Department of Prisons
The territory of the NCDOP ranges from the
sandy beaches of the Atlantic Ocean to the
rocky Blue Ridge Mountains. The state's 81
prisons house 32,000 inmates (average daily
census) and accommodate 20,000 new
admissions each year. HIV-infected patients
are neither isolated nor segregated, although
patients who have more complicated management issues are housed in proximity to clinics
staffed by HIV-experienced physicians.

many as 40 to 50% of patients with HIV infection remain unidentified, on par with figures
that have been described for other states (see
Spotlight on the New York Department of
Corrections, HEPP News, May 1999). Of
those 530 or so inmates that have HIV infection, on average 36% (190) had CDC-defined
AIDS, 64% (334) had HIV, 12% (64) were
female, 86% (459) were between 24-44 years
of age, and 84% (448) were African American.
According to Barbara Pohlman, MD MPH,
Health Services Director/Medical Director, the
outreach nurse program (described in this
issue) is a critical component of HIV management in the NCDOC. She reports that the HIV
treatment program incorporates the most
important precepts of correctional health care:
good medical practice, good for the health of
inmates, good for public health, and fiscally
responsible.

HIV testing is voluntary, upon inmate request,
when clinically indicated, or in the event of a
bloodborne pathogen exposure with a consent
form required prior to testing. Education about
testing is provided at intake. As has been
described for other states with voluntary testing (1, 2) the number of inmates known to be
infected with HIV (identified using voluntary
testing or self-report) is less than the total
number of inmates who are believed to be
HIV speciality care is provided under contract
infected.
with four private HIV specialists and, for a few
On any given day in 1998, the NCDOP aver- of the facilities, by contracting HIV specialists
aged 534 known HIV-infected inmates in the from the University of North Carolina at Chapel
system.(3) The literature estimates that as Hill. The HIV specialists work with the outreach

FAX HEPP NEWS BACK AT 800.671.1754

nurse to design treatment regimens and monitor the progression of HIV disease. All
approved medications for HIV-therapy are currently on the formulary. HIV infected inmates
have had access to HAART since 1998, consequently, AIDS deaths in the NCDOP have
followed national trends (4). Inmates have also
had access to clinical trials at selected facilities. The trial protocols are scrutinized by the
UNC human studies committees and by NC
DOP authorities for adherence to guidelines
set out by the FDA and the Belmont
Committee Report (see Dr. Wohl's article on
page 1).
REFERENCES:
1) De Groot, AS, Hammet TM. Barriers to care of
HIV-infected inmates: a public health concern.
AIDS Reader, May/ June 1996; 78-87.
2) NYS DOC Spotlight, HEPP News, May 1999;
2(5).
3) Personal Communication. Barbara Pohlman,
Medical Director at NCDOP, and Maruschack, L.
HIV in Prisons and Jails, Bureau of Justice
Statistics, 1999. http://www.ojp.usdoj.gov/bjs/
4) MMWR 1999 Jan 8; 47 (51&52): 1115-7.

FOR ANY OF THE FOLLOWING: (please print clearly or type)

____ Yes, I would like to add/update/correct (circle one) my contact information for my complimentary subscription of HEPPNews fax newsletter.
____ Yes, I would like to sign up the following colleague to receive a complimentary subscription of HEPPNews fax newsletter.
____ Yes, I would like to order the following back issues (please include volume/issue/date).
____ Yes, I would like my HEPP News to be delivered as an attached PDF file in an e-mail (rather than have a fax).

NAME: ____________________________________________________________________________________________
TITLE: __________________________________________________ E-MAIL ADDRESS: ________________________
FACILITY: ________________________________________________ (Optional) # of Inmates:

____________________

ADDRESS: ________________________________________________________________________________________
FAX: ____________________________________________________ PHONE:
SIGNATURE: ____________________________________________ DATE:

________________________________
__________________________________

Subscribe to HIV Inside

A new quarterly newsletter addressing HIV-management issues specific to correctional care.
If you are interested in receiving this free publication, please fill out the form below. In addition to receiving HIV Inside, this contact information will be entered into an HIV-management database, allowing additional education materials to be forwarded.
Name ________________________________________________________________________________________
Title

________________________________________________________________________________________

Agency/Facility ________________________________________________________________________________
Address________________________________________________________________________
City ______________________________________________ State ______________________ Zip __________
Phone ____________________________________________ Fax ______________________________________
Fax back to Brendan Maney at World Health CME at 212.481.8534
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Self-Assessment Test for Continuing Medical Education Credit

Brown University School of Medicine designates this educational activity for 1 hour in category 1 credit toward the AMA Physicians
Recognition Award. To be eligible for CME credit, answer the questions below by circling the letter next to the correct answer to each
of the questions. A minimum of 70% of the questions must be answered correctly. This activity is eligible for CME credit through October
15, 1999. The estimated time for completion of this activity is one hour and there is no fee for participation in this activity.

True or False:
1. __ With the exception of the Belmont report, all codes
and commission reports require that coercion, constraint, duress, or elements of force be absent when
a subject agrees to participate in a study.
2. __ Prisoners should not be selected for research when
other, less vulnerable and burdened populations can
address the scientific question being addressed.
3. __ Ethicists agree that prisoners should be denied the
opportunity to volunteer for human subject research.
4. Research considered appropriate for prisoner participation DOES NOT include:
a) studies of criminal behavior
b) prison life
c) conditions affecting prisoners as a class
d) phase I and I I treatment trials
e) all of the above
5. Studies about nurse HIV case management have
shown that
a) service integration is an essential part of the
health care program
b) skilled nurse case managers ensure better HIV
care in the correctional setting
c) nurse HIV case managers decrease the need
for HIV medical specialists
d) trusting caregiver/client relationships are easier
to achieve in the correctional setting
e) all of the above
f) a, b

6. The main components of a successful HIV nurse case
management program DOES NOT include:
a) discharge planning
b) a trusting client/caregiver relationship
c) integrated service programs
d) equal numbers of HIV medical specialists and
nurse case managers
e) any of the above

HEPP News Evaluation
5 Excellent

4 Very Good

3 Fair

2 Poor

1 Very Poor

1. Please evaluate the following sections with respect to:
educational value

clarity

main article

5 4 3 2 1

5 4 3 2 1

secondary
article

5 4 3 2 1

5 4 3 2 1

HEPPigram

5 4 3 2 1

5 4 3 2 1

updates

5 4 3 2 1

5 4 3 2 1

save the date

5 4 3 2 1

5 4 3 2 1

2. Do you feel that HEPP News helps you in your work?
Why or why not?

3. What future topics should HEPP News address?

4. How can HEPP News be made more useful to you?

BROWN UNIVERSITY SCHOOL OF MEDICINE  OFFICE

OF

CONTINUING MEDICAL EDUCATION  BOX G-A2  PROVIDENCE, RI 02912

The Brown University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education activities for physicians. This activity has been planned and implemented in accordance with the Essentials and Standards
of the ACCME.
The use of the Brown University School of Medicine name implies review of the educational format and material only. The opinions, recommendations and editorial positions expressed by those whose input is included in this bulletin are their own. They do not represent or speak for the
Brown University School of Medicine.

For Continuing Medical Education credit please complete the following and mail or fax to 401.863.2660
Be sure to print clearly so that we have the correct information for you.
Name __________________________________________________________________ Degree
Address

____________________

____________________________________________________________________________________________

____________________________________________________________________________________________________
City

____________________________________________________ State

________ Zip ________________________

Telephone ________________________________________________ Fax ______________________________________
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